Sichuan Bojia Pharmaceutical

Sichuan Bojia Pharmaceutical is a Chinese pharmaceutical company dedicated to the research, development, and manufacturing of high-quality chemical APIs and finished dosage forms. Established in 2015 and headquartered in Chengdu, the company focuses on therapeutic areas including cardiovascular health, metabolic disorders, and anti-infectives. Bojia operates a state-of-the-art R&D center and a large-scale GMP-compliant manufacturing facility located in Meishan, Sichuan. The company is particularly recognized for its expertise in the synthesis of complex anticoagulants such as Rivaroxaban and Apixaban. By integrating R&D with industrial-scale production, Sichuan Bojia Pharmaceutical serves both the domestic Chinese market and international clients through API supply and contract manufacturing services.